NNRTI-associated mutations in patients with virologic failure on first-line regimen in Yekaterinburg

NNRTI-associated mutations in patients with virologic failure on first-line regimen in Yekaterinburg

Bibliographic Details
Main Authors:	A. Chuykov, O. Samarina, D. Bikmukhametov
Format:	Article
Language:	English
Published:	Elsevier 2014-04-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S120197121400736X

Similar Items

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
by: Phasomsap Chayapa, et al.
Published: (2011-10-01)

Virologic response of treatment experienced HIV-infected Ugandan children and adolescents on NNRTI based first-line regimen, previously monitored without viral load
by: Phionah Kibalama Ssemambo, et al.
Published: (2021-03-01)

Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya
by: Ingrid A. Beck, et al.
Published: (2020-01-01)

Cost-effectiveness of early treatment with first-line NNRTI-based HAART regimens in the UK, 1996-2006.
by: Eduard J Beck, et al.
Published: (2011-01-01)

Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration
by: Soo-Yon Rhee, et al.
Published: (2017-04-01)

Liver transplantation in Yekaterinburg: the first experience
by: E. N. Bessonova, et al.
Published: (2018-08-01)

Early virological suppression despite high frequency NNRTI resistance following perinatal prophylaxis in HIV-infected African infants
by: Coovadia Hoosen, et al.
Published: (2008-04-01)

NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved
by: Ana M. Benedicto, et al.
Published: (2021-07-01)

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
by: Suntisuklappon Busakorn, et al.
Published: (2010-10-01)

Association between time spent with residual viremia after achievement of virological suppression and type of first-line antiretroviral regimen
by: A. Lazzarin, et al.
Published: (2017-12-01)

Predictors of Virological Failure in HIV Patients Receiving First Line Antiretroviral Therapy with Good Adherence
by: Farid Kurniawan, et al.
Published: (2017-03-01)

From the history of yekaterinburg urbanonymy
by: Kachalkova Julija Aleksandrovna
Published: (2013-04-01)

Specify of electoral culture of Yekaterinburg
by: Mukhametov Ruslan Salikhovich
Published: (2014-10-01)

EXPERIENCE OF VACCINE PREVENTION FOR VARICELLA IN YEKATERINBURG
by: O.L. Ksenofontova, et al.
Published: (2010-07-01)

EXPERIENCE OF VACCINE PREVENTION FOR VARICELLA IN YEKATERINBURG
by: O.L. Ksenofontova, et al.
Published: (2010-07-01)

Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child.
by: Elizabeth S Machado, et al.
Published: (2009-01-01)

Before the First World War: Reconstruction of the Yekaterinburg City Population in 1913
by: Dmitry S. Bakharev, et al.
Published: (2020-12-01)

Low-Frequency NNRTI-Resistant HIV-1 Variants and Relationship to Mutational Load in Antiretroviral-Naïve Subjects
by: Shaili Gupta, et al.
Published: (2014-09-01)

HIV-1 resistance patterns to integrase inhibitors in Chilean patients with virological failure on raltegravir-containing regimens
by: Pablo Ferrer, et al.
Published: (2020-09-01)

High rates of transmitted NNRTI resistance among persons with acute HIV infection in Malawi: implications for first-line dolutegravir scale-up
by: Sarah E. Rutstein, et al.
Published: (2019-02-01)

Impact of first-line protease inhibitors on predicted resistance to tipranavir in HIV-1-infected patients with virological failure
by: Chen Mao-Yuan, et al.
Published: (2009-09-01)

Sverdlovsk-Yekaterinburg Musical and Poetic School
by: Vitaliy Aleksandrovich Gavrikov
Published: (2018-03-01)

Poisonings by Cardiovascular Drugs in Yekaterinburg, Russia
by: Konstantin M. Brusin, et al.
Published: (2016-03-01)

The structure of the soft drinks supply at the market of Yekaterinburg
by: M. P. Solov'eva, et al.
Published: (2017-05-01)

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
by: Eva Agnes Odongpiny Laker, et al.
Published: (2019-03-01)

Rector and the First Teacher of German school of Yekaterinburg Bernhard Stermer (1735-1740)
by: A. M. Safronova
Published: (2019-07-01)

Missionary Work in the Yekaterinburg Diocese in the late XIX and early XX century (on the basis of the Yekaterinburg Diocesan Bulletin, 1886–1917)
by: Dmitry Kashtanov
Published: (2015-08-01)

HIV-1 genotypic drug resistance in patients with virological failure to single-tablet antiretroviral regimens in southern Taiwan
by: Tsai HC, et al.
Published: (2018-08-01)

Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
by: Annelot F Schoffelen, et al.
Published: (2013-01-01)

Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing.
by: Max Lataillade, et al.
Published: (2012-01-01)

Potential of Sverdlovsk Oblast and Yekaterinburg Environmental Sector
by: Belik Irina, et al.
Published: (2016-01-01)

Hodonymy of Chengdu and Yekaterinburg: a Comparative Aspect
by: E. E. Ivanova, et al.
Published: (2020-12-01)

Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure
by: Nilkamhang Samruay, et al.
Published: (2009-12-01)

Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure
by: Manosuthi Weerawat, et al.
Published: (2012-03-01)

Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique
by: Andrea De Luca, et al.
Published: (2017-09-01)

Multiple dosage forms of the NNRTI microbicide dapivirine: product development and evaluation
by: Romano Joseph
Published: (2006-12-01)

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV
by: Oliver T. Stirrup, et al.
Published: (2019-10-01)

Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting
by: Wassim Chehadeh, et al.
Published: (2020-05-01)

Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status
by: M. Yu. Fedyanin, et al.
Published: (2018-05-01)

Virologic suppression in patients with a documented M184V/I mutation based on the number of active agents in the antiretroviral regimen
by: Mallory T Mouradjian, et al.
Published: (2020-09-01)